Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Symbotic to Acquire Walmart’s Advanced Systems and Robotics Business and Sign Related Commercial Agreement
-
STRAWBERRY FIELDS REIT TO PRESENT AT THE 2025 SEQUIRE INVESTOR SUMMIT IN PUERTO RICO
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Learning Technologies Group plc
-
TransUnion Announces Agreement to Acquire Majority Ownership of the Consumer Credit Business of Buró de Crédito
-
Form 8.5 (EPT/RI) - Warpaint London Plc
-
Outlook Therapeutics® Announces Complete Twelve Week Efficacy and Safety Results of NORSE EIGHT Clinical Trial
-
Beam Global to Participate at the 2025 Sequire Investor Summit in Puerto Rico
-
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc
-
Biz2Credit Small Business Earnings Report Finds SMB Earnings Plummeted in 4Q’24
-
Crestline Hotels & Resorts Assumes Management of Five Senses Hospitality Portfolio
-
Form 8.5 (EPT/RI) - Brand Architekts Group plc
-
Information mensuelle relative au nombre total de droit de vote Décembre 2024
-
BitconeMine Launches New Services for Free and Transparent Digital Asset Solutions
-
Net Asset Value(s)
-
Bitget Becomes the First CEX to Introduce Bittensor's TAO PoS Staking
-
Huize Launches Customized Mid-Tier Medical Insurance Product “PrimeMed” in Partnership with CCIC and MSH CHINA
-
Ohio Partners with Anduril to “Rebuild the Arsenal” for Essential National Security Needs
-
Acronis Announces New #TeamUp Partnership with Brentford FC, Supported by Littlefish
-
Bitget Becomes the First CEX to Introduce Bittensor's TAO PoS Staking
-
KFSHRC Launches Precision Medicine Services in Family Medicine Clinics to Enhance Access to the Latest Genetic Tests
-
Dimensional Fund Advisors Ltd. : Form 8.3 - HARGREAVES LANSDOWN PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - BRITVIC PLC - Ordinary Shares
-
Issue of Equity
-
Elis: Half-yearly report relative to the liquidity contract as of 31 December 2024
-
Member of the Board, Lars Christian Tofft, has suddenly passed away
-
From Data to Movement: The Breakthrough Helping Paralyzed Patients Walk Again
-
Share Buyback Transaction Details January 9 – January 15, 2025
-
DSV - 2024 Annual Report conference call
-
Form 8.5 (EPT/RI)-De La Rue plc
-
Financial calender for funds managed by Storebrand Asset Management AS
-
K92 Mining Announces Management Changes to Strengthen Leadership Team
-
KraneShares Launches Global Carbon Strategy ETC (KRBN) on London Stock Exchange
-
Statkraft and Suomen Voima sign first PPA in Sweden
-
Municipality Finance issues a EUR 20 million tap under its MTN programme
-
Actimed Therapeutics appoints Dr Fabio Dorigotti as Chief Medical Officer to drive further pipeline development for cancer cachexia and other muscle wasting disorders
-
Transactions by persons discharging managerial responsibilities and persons closely associated with them
-
Capgemini and Ascendance extend their partnership to accelerate industrialization of decarbonized air transport
-
Trifork chosen as sole supplier for new IT development framework agreement with Aalborg University
-
Defiance Launches SOFX, The First 2X Leveraged Single-Stock ETF on SoFi Technologies, Inc.
-
SAGA Metals Provides In-Depth Summary of Radar Titanium-Vanadium Project on Eve of Drilling
-
Phonak expands award-winning Infinio portfolio with two new custom hearing aids
-
Aspo’s Shareholders’ Nomination Board’s proposals to the Annual Shareholders' meeting 2025
-
Stellantis Reports Q4 2024 Consolidated Shipment Estimates
-
Inside information: Vaisala’s 2024 operating result (EBIT) higher than estimated earlier and Vaisala provides preliminary information
-
Information regarding the decision of the Director of the Prudential Supervision Department of the Bank of Lithuania
-
Transaction in Own Shares
-
Start of Day Message
-
Santhera Pharmaceuticals Provides Update on Royalty Agreement for AGAMREE® (Vamorolone) and Warrants held by Idorsia
-
Santhera Receives Positive NICE Final Guidance for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy
-
Richemont reports strong performance with sales up 10% for its third quarter ended 31 December 2024
